Moody’s revises Milford Regional Medical Center’s outlook to negative

Moody’s Investors Service has affirmed the “Baa3” rating on Milford (Mass.) Regional Medical Center’s $108 million of outstanding revenue bonds and revised the outlook to negative from stable.

Advertisement

The rating affirmation is based on multiple factors, including MRMC’s relatively stable position as a community hospital.

The outlook revision reflects MRMC’s deteriorating cash flow through nine months of fiscal year 2016, challenged operations and weakening debt service coverage.

More articles on healthcare finance:
July revenues exceed $400k for Certive Solutions
Jopari aims to invigorate attachments exchange for providers
Kindred to close 2nd Texas long-term care hospital

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.